New Data, New Perspectives in Ovarian Cancer: Experts Discuss the Current Paradigm and Long-term Benefits of PARP Inhibitor Therapy

Download All
Gain a deeper understanding of how PARP inhibitors fit into current treatment approaches in ovarian cancer in this on-demand webcast and audio podcast, then download the slides for use in your own presentations.
Nicoletta Colombo, MD
person default
Philipp Harter, MD, PhD
person default
Alexandra Leary, MD, PhD

On-Demand Webcast

Watch this on-demand webcast capturing a live CCO webinar during IGCS 2021 of experts discussing the evolving strategies and expanding role of PARP inhibitors in managing patients with ovarian cancer.

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 4, 2021 Expired: October 3, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue